Sep 15, 2022   SOURCE: BusinessWire

World Vagus Nerve Stimulators (VNS) Pipeline Market Report 2022: Stages of Development, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials and Key Companies - ResearchAndMarkets.com

The "Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive information about the Vagus Nerve Stimulators (VNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A VNS is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically-implanted electrodes to target the vagus nerve.

Scope

  • Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vagus Nerve Stimulators (VNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Vagus Nerve Stimulators (VNS) Overview

3 Products under Development

3.1 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development

3.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory

3.3 Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path

3.4 Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date

3.5 Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials

4 Vagus Nerve Stimulators (VNS) - Pipeline Products under Development by Companies

4.1 Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development

4.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development

5 Vagus Nerve Stimulators (VNS) Companies and Product Overview

5.1 Adriakaim Inc Company Overview

5.2 Afferent Technologies Company Overview

5.3 Aucta Technologies Inc Company Overview

5.4 Boston Scientific Corp Company Overview

5.5 Cala Health Inc Company Overview

5.6 CerboMed GmbH Company Overview

5.7 Cyberonics Inc Company Overview

5.8 DuoCure Ltd. Company Overview

5.9 ElectroCore Inc Company Overview

5.10 Evren Technologies Inc Company Overview

5.11 Flint Rehabilitation Company Overview

5.12 FRD Accel LLC Company Overview

5.13 LivaNova PLC Company Overview

5.14 Medical University of South Carolina Company Overview

5.15 MicroTransponder Inc Company Overview

5.16 Nemechek Technologies LLC Company Overview

5.17 Neuroloop Gmbh Company Overview

5.18 Nexeon MedSystems Inc Company Overview

5.19 Otto Bock HealthCare GmbH Company Overview

5.20 Parasym Ltd Company Overview

5.21 Pulsetto UAB Company Overview

5.22 Pulsus Medical LLC (Inactive) Company Overview

5.23 Purdue University Company Overview

5.24 ReShape Lifesciences Inc Company Overview

5.25 Setpoint Medical Corp Company Overview

5.26 Soterix Medical Inc Company Overview

5.27 SUNY Downstate Medical Center Company Overview

5.28 Synergia Medical SA Company Overview

5.29 AURIMOD Gmb Company Overview

5.30 The Feinstein Institute for Medical Research Company Overview

5.31 Trifectas Medical Corp. Company Overview

5.32 University of Alabama Company Overview

5.33 University of Auckland Company Overview

5.34 University of Pittsburgh Company Overview

5.35 University of Wisconsin Madison Company Overview

6 Vagus Nerve Stimulators (VNS)- Recent Developments

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/6ldh3k